Fatty acids and evolving roles of their proteins in neurological, cardiovascular disorders and cancers

Abstract

The dysregulation of fat metabolism is involved in various disorders, including neurodegenerative, cardiovascular, and cancers. The uptake of long-chain fatty acids (LCFAs) with 14 or more carbons plays a pivotal role in cellular metabolic homeostasis. Therefore, the uptake and metabolism of LCFAs must constantly be in tune with the cellular, metabolic, and structural requirements of cells. Many metabolic diseases are thought to be driven by the abnormal flow of fatty acids either from the dietary origin and/or released from adipose stores. Cellular uptake and intracellular trafficking of fatty acids are facilitated ubiquitously with unique combinations of fatty acid transport proteins and cytoplasmic fatty acid-binding proteins in every tissue. Extensive data are emerging on the defective transporters and metabolism of LCFAs and their clinical implications. Uptake and metabolism of LCFAs are crucial for the brain's functional development and cardiovascular health and maintenance. In addition, data suggest fatty acid metabolic transporter can normalize activated inflammatory response by reprogramming lipid metabolism in cancers. Here we review the current understanding of how LCFAs and their proteins contribute to the pathophysiology of three crucial diseases and the mechanisms involved in the processes.

Keywords: Alzheimer's disease; Arachidnoic acid,; Blood brain barrier; Brain; COX; Cancers; Cardiovascular disease; Docosahexaenoic acid; Endothelium; FABPpm; FABPs; FAT/CD36; FATPs; Inflammation; LCPUFAs; Long-chain fatty acids; NEFAs; Neurology; Prostaglandins; Toll-like receptors; VEGF; n-3/n-6 Fatty acids.